Tech Company Financing Transactions

MacuSight Funding Round

MacuSight secured a $700.2 thousand venture capital round on 3/31/2008. Investors included Alloy Ventures, Frazier Healthcare Partners and InterWest Partners.

Transaction Overview

Company Information

Company Status

Out of Business

Industry

Biopharmaceutical

Mailing Address

32980 Alvarado-Niles Road 846
Union City, CA 94587
USA

Phone

(510) 400-1440

Website

www.macusight.com

Email Address

[email protected]

Overview

MacuSight is a privately-held pharmaceutical company focused on developing innovative therapeutics for the treatment of severe ocular diseases and conditions. The company is dedicated to preserving patients' vision by identifying known, highly-potent and broad-acting small molecule drug compounds that may possess efficacy in treating and/or preventing diseases or conditions of the eye.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

David Weber

        

Chief Medical Officer

Joel Naor

        

VP - General Counsel

Philip Reilly

        

VP - Operations

Gerald Wroblewski

        

VP - R & D

Thierry Nivaggioli

        

Browse more venture capital transactions:

Prev: 3/31/2008: Reality Digital venture capital transaction
Next: 3/31/2008: Yorktel venture capital transaction

Share this article

About Our VC Transactions Data

Our team works diligently to report on all VC transactions involving tech companies. All VC database entries on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary